vs
Pediatrix Medical Group, Inc.（MD）与Rithm Capital Corp.（RITM）财务数据对比。点击上方公司名可切换其他公司
Rithm Capital Corp.的季度营收约是Pediatrix Medical Group, Inc.的1.7倍（$828.2M vs $493.8M），Rithm Capital Corp.净利率更高（13.2% vs 6.8%，领先6.4%），Rithm Capital Corp.同比增速更快（508.5% vs -1.7%），过去两年Pediatrix Medical Group, Inc.的营收复合增速更高（-0.1% vs -17.9%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Rithm Capital Corp.是总部位于美国纽约的投资管理机构，核心业务聚焦房地产投资与另类资产投资，依托专业的投研团队和成熟的市场运营经验，为合作伙伴及投资者提供优质的资产配置解决方案与长期收益回报。
MD vs RITM — 直观对比
营收规模更大
RITM
是对方的1.7倍
$493.8M
营收增速更快
RITM
高出510.2%
-1.7%
净利率更高
RITM
高出6.4%
6.8%
两年增速更快
MD
近两年复合增速
-17.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $828.2M |
| 净利润 | $33.7M | $109.5M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | 29.9% |
| 净利率 | 6.8% | 13.2% |
| 营收同比 | -1.7% | 508.5% |
| 净利润同比 | 10.5% | 27.7% |
| 每股收益（稀释后） | $0.40 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDRITM
| Q1 26 | — | $828.2M | ||
| Q4 25 | $493.8M | $1.5B | ||
| Q3 25 | $492.9M | $1.1B | ||
| Q2 25 | $468.8M | $1.2B | ||
| Q1 25 | $458.4M | $768.4M | ||
| Q4 24 | $502.4M | $2.1B | ||
| Q3 24 | $511.2M | $619.5M | ||
| Q2 24 | $504.3M | $1.2B |
净利润MDRITM
| Q1 26 | — | $109.5M | ||
| Q4 25 | $33.7M | $85.0M | ||
| Q3 25 | $71.7M | $221.5M | ||
| Q2 25 | $39.3M | $311.7M | ||
| Q1 25 | $20.7M | $78.8M | ||
| Q4 24 | $30.5M | $290.2M | ||
| Q3 24 | $19.4M | $121.7M | ||
| Q2 24 | $-153.0M | $235.6M |
营业利润率MDRITM
| Q1 26 | — | 29.9% | ||
| Q4 25 | 9.9% | 13.8% | ||
| Q3 25 | 13.8% | 21.4% | ||
| Q2 25 | 12.8% | 25.2% | ||
| Q1 25 | 7.0% | 7.4% | ||
| Q4 24 | 7.8% | 23.8% | ||
| Q3 24 | 6.6% | 7.3% | ||
| Q2 24 | -31.3% | 23.6% |
净利率MDRITM
| Q1 26 | — | 13.2% | ||
| Q4 25 | 6.8% | 5.7% | ||
| Q3 25 | 14.5% | 20.0% | ||
| Q2 25 | 8.4% | 25.6% | ||
| Q1 25 | 4.5% | 10.3% | ||
| Q4 24 | 6.1% | 14.0% | ||
| Q3 24 | 3.8% | 19.7% | ||
| Q2 24 | -30.3% | 19.2% |
每股收益（稀释后）MDRITM
| Q1 26 | — | $0.12 | ||
| Q4 25 | $0.40 | $0.09 | ||
| Q3 25 | $0.84 | $0.35 | ||
| Q2 25 | $0.46 | $0.53 | ||
| Q1 25 | $0.24 | $0.07 | ||
| Q4 24 | $0.37 | $0.50 | ||
| Q3 24 | $0.23 | $0.20 | ||
| Q2 24 | $-1.84 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | — |
| 总债务越低越好 | $570.5M | — |
| 股东权益账面价值 | $865.9M | $9.1B |
| 总资产 | $2.2B | $53.4B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDRITM
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | $1.8B | ||
| Q3 25 | $340.1M | $1.6B | ||
| Q2 25 | $224.7M | $1.6B | ||
| Q1 25 | $99.0M | $1.5B | ||
| Q4 24 | $229.9M | $1.5B | ||
| Q3 24 | $103.8M | $1.6B | ||
| Q2 24 | $19.4M | $1.2B |
总债务MDRITM
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | $35.4B | ||
| Q3 25 | $577.2M | $32.2B | ||
| Q2 25 | $583.9M | $31.2B | ||
| Q1 25 | $590.5M | $32.2B | ||
| Q4 24 | $597.1M | $32.6B | ||
| Q3 24 | — | $29.6B | ||
| Q2 24 | — | $30.1B |
股东权益MDRITM
| Q1 26 | — | $9.1B | ||
| Q4 25 | $865.9M | $8.4B | ||
| Q3 25 | $890.7M | $8.5B | ||
| Q2 25 | $833.8M | $7.9B | ||
| Q1 25 | $789.2M | $7.8B | ||
| Q4 24 | $764.9M | $7.8B | ||
| Q3 24 | $732.5M | $7.7B | ||
| Q2 24 | $706.5M | $7.3B |
总资产MDRITM
| Q1 26 | — | $53.4B | ||
| Q4 25 | $2.2B | $53.1B | ||
| Q3 25 | $2.2B | $47.2B | ||
| Q2 25 | $2.1B | $44.3B | ||
| Q1 25 | $2.0B | $45.3B | ||
| Q4 24 | $2.2B | $46.0B | ||
| Q3 24 | $2.1B | $42.3B | ||
| Q2 24 | $2.0B | $42.0B |
负债/权益比MDRITM
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 4.20× | ||
| Q3 25 | 0.65× | 3.79× | ||
| Q2 25 | 0.70× | 3.92× | ||
| Q1 25 | 0.75× | 4.14× | ||
| Q4 24 | 0.78× | 4.18× | ||
| Q3 24 | — | 3.87× | ||
| Q2 24 | — | 4.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.39× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDRITM
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $-114.6M | ||
| Q3 25 | $137.3M | $-2.0B | ||
| Q2 25 | $137.2M | $-557.1M | ||
| Q1 25 | $-117.5M | $1.4B | ||
| Q4 24 | $133.0M | $-1.8B | ||
| Q3 24 | $91.8M | $768.1M | ||
| Q2 24 | $107.0M | $-55.7M |
现金转化率MDRITM
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | -1.35× | ||
| Q3 25 | 1.91× | -9.22× | ||
| Q2 25 | 3.49× | -1.79× | ||
| Q1 25 | -5.66× | 18.03× | ||
| Q4 24 | 4.36× | -6.04× | ||
| Q3 24 | 4.72× | 6.31× | ||
| Q2 24 | — | -0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RITM
| Servicing revenue, net | $375.1M | 45% |
| Other | $234.9M | 28% |
| Gain on originated residential mortgage loans, held-for-sale, net | $195.0M | 24% |
| Other revenue | $23.3M | 3% |
